[ad_1]
Trump complains about the timing of the vaccine notification
Acting President Donald Trump described the announcement of promising results by the makers of a corona vaccine a few days after the US election as politically motivated. The pharmaceutical company Pfizer “did not have the courage” to announce the good news before the election, it criticized Trump on Monday night (local time) on Twitter. The American company is working on the vaccine with the German company Biontech.
Trump also criticized the Food and Drug Administration (FDA) of his administration, which handles approval in his tweet. The FDA should have announced the results sooner, he complained. “Not for political reasons, but to save lives,” Trump wrote. During the election campaign, he had repeatedly promised there would be good news about vaccines before the vote and was apparently expecting a political tailwind.
“The FDA and the Democrats didn’t want me to have a successful vaccine before the election, so it came out five days later,” Trump wrote on Twitter. His administration’s FDA is led by Stephen Hahn, whom the Republican Trump himself appointed. Biontech and Pfizer were the first Western manufacturers to publish promising results, but limited in the scope of details, on Monday. Consequently, your vaccine offers more than 90 percent protection against Covid-19. The companies want to apply for emergency approval from the FDA starting next week.
The Pfizer Group, which is developing the vaccine in cooperation with German company Biontech, has already rejected allegations that the research work is influenced by politics. You “move to the rhythm of science,” the company explained.
Pfizer itself learned of the interim good results from the late testing phase on Sunday after independent data experts met. The announcement doesn’t mean you have a vaccine at your fingertips – even if all goes well, it’s pretty unlikely that a vaccine will be available before the end of the year. And the starting doses will be limited. Pfizer also cautioned that the initially determined vaccination protection rate could change at the end of the study.
